Horizon Bancorp Inc /In/ Edwards Lifesciences Corp Transaction History

Horizon Bancorp Inc /In/

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$74.26 - $84.51 $5,123 - $5,831	-69 Reduced 34.67%	130 $11,000
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $149,577 - $191,493	-2,190 Reduced 91.67%	199 $15,000
Q3 2020 Nov 12, 2020	SELL	$67.19 - $87.44 $4,300 - $5,596	-64 Reduced 2.61%	2,389 $191,000
Q2 2020 Aug 10, 2020	BUY	$57.54 - $76.95 $93,790 - $125,428	1,630 Added 198.06%	2,453 $170,000
Q1 2020 Apr 20, 2020	SELL	$52.41 - $81.0 $11,320 - $17,496	-216 Reduced 20.79%	823 $155,000
Q4 2019 Feb 11, 2020	BUY	$71.7 - $82.09 $74,496 - $85,291	1,039 New	1,039 $242,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Horizon Bancorp Inc /In/, based on Form 13F filings with the SEC.

Stay updated on Horizon Bancorp Inc /In/ with notifications on news.